We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Pushes Presubmission Talks for Orphan Drug Filings
EMA Pushes Presubmission Talks for Orphan Drug Filings
The European Medicines Agency is asking sponsors to give two months’ advance notice of their intent to file orphan drug applications to help the agency meet its 90-day review deadline.